European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
Faster recovery in patients with facial nerve palsy treated with contralateral botulinum toxin injection: a case-control study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Park Jung Mee, Lim Ji Hyung, Han Jae Sang, Park Shi Nae
Аннотация
PURPOSE: Botulinum toxin (BTX, Botox) is increasingly used as an adjunct therapy to oral steroids in the management of facial paralysis, with positive outcomes. This study aimed to evaluate the additive effect of BTX injection on the non-paralyzed side and propose optimal injection timing for recovery time.
METHODS: A total of 48 atraumatic facial paralysis patients who visited Seoul St. Mary's hospital for facial palsy between June 2015 and May 2021 were retrospectively reviewed. Patients were divided into 2 groups: the BTX injection group (BG) and the non-BTX injection group (NBG). We analyzed the recovery rate of facial palsy to H-B grade II or lower in each group, and conducted telephone surveys to collect subjective satisfaction data after BTX injection.
RESULTS: Days of recovery to H-B grade II from symptom onset were 93.0 ± 62 and 68.7 ± 66.6 in NBG and BG, respectively. Early BTX injection (less than 17.5 days from symptom onset) was a prognostic factor for recovery to H-B grade II in less than 1 month (R2 = 0.935, B = 1.738, p < 0.001). Telephone survey showed subjective satisfaction in all aspects 1 month after BTX injection: function (83.3%), cosmetic (70.9%), and recovery (54.2%).
CONCLUSION: Early contralateral facial BTX injection can shorten the recovery period of atraumatic facial palsy.
METHODS: A total of 48 atraumatic facial paralysis patients who visited Seoul St. Mary's hospital for facial palsy between June 2015 and May 2021 were retrospectively reviewed. Patients were divided into 2 groups: the BTX injection group (BG) and the non-BTX injection group (NBG). We analyzed the recovery rate of facial palsy to H-B grade II or lower in each group, and conducted telephone surveys to collect subjective satisfaction data after BTX injection.
RESULTS: Days of recovery to H-B grade II from symptom onset were 93.0 ± 62 and 68.7 ± 66.6 in NBG and BG, respectively. Early BTX injection (less than 17.5 days from symptom onset) was a prognostic factor for recovery to H-B grade II in less than 1 month (R2 = 0.935, B = 1.738, p < 0.001). Telephone survey showed subjective satisfaction in all aspects 1 month after BTX injection: function (83.3%), cosmetic (70.9%), and recovery (54.2%).
CONCLUSION: Early contralateral facial BTX injection can shorten the recovery period of atraumatic facial palsy.